Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection

Coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a serious infectious disease that has led to a global pandemic with high morbidity and mortality. High-affinity neutralizing antibody is important for controlling infection, whic...

Full description

Bibliographic Details
Main Authors: Dawei Cui, Yuan Tang, Qi Jiang, Daixi Jiang, Yun Zhang, Yan Lv, Dandan Xu, Jian Wu, Jue Xie, Chengping Wen, Liwei Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.731100/full
id doaj-ee1f78f4a641477ead9d34e6201a6e21
record_format Article
spelling doaj-ee1f78f4a641477ead9d34e6201a6e212021-09-16T04:52:56ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-09-011210.3389/fimmu.2021.731100731100Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 InfectionDawei Cui0Yuan Tang1Yuan Tang2Qi Jiang3Daixi Jiang4Yun Zhang5Yan Lv6Dandan Xu7Jian Wu8Jue Xie9Chengping Wen10Liwei Lu11Liwei Lu12Department of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Pathology and Shenzhen Institute of Research and Innovation, The University of Hong Kong, Hong Kong, Hong Kong, SAR ChinaChongqing International Institute for Immunology, Chongqing, ChinaDepartment of Blood Transfusion, Shaoxing People’s Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaSchool of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaSchool of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, ChinaDepartment of Pathology and Shenzhen Institute of Research and Innovation, The University of Hong Kong, Hong Kong, Hong Kong, SAR ChinaChongqing International Institute for Immunology, Chongqing, ChinaCoronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a serious infectious disease that has led to a global pandemic with high morbidity and mortality. High-affinity neutralizing antibody is important for controlling infection, which is closely regulated by follicular helper T (Tfh) cells. Tfh cells play a central role in promoting germinal center reactions and driving cognate B cell differentiation for antibody secretion. Available studies indicate a close relationship between virus-specific Tfh cell-mediated immunity and SARS-CoV-2 infection progression. Although several lines of evidence have suggested that Tfh cells contribute to the control of SARS-CoV-2 infection by eliciting neutralizing antibody productions, further studies are needed to elucidate Tfh-mediated effector mechanisms in anti-SARS-CoV-2 immunity. Here, we summarize the functional features and roles of virus-specific Tfh cells in the immunopathogenesis of SARS-CoV-2 infection and in COVID-19 vaccines, and highlight the potential of targeting Tfh cells as therapeutic strategy against SARS-CoV-2 infection.https://www.frontiersin.org/articles/10.3389/fimmu.2021.731100/fullCOVID-19SARS-CoV-2Tfh cellsB cellsneutralizing antibody
collection DOAJ
language English
format Article
sources DOAJ
author Dawei Cui
Yuan Tang
Yuan Tang
Qi Jiang
Daixi Jiang
Yun Zhang
Yan Lv
Dandan Xu
Jian Wu
Jue Xie
Chengping Wen
Liwei Lu
Liwei Lu
spellingShingle Dawei Cui
Yuan Tang
Yuan Tang
Qi Jiang
Daixi Jiang
Yun Zhang
Yan Lv
Dandan Xu
Jian Wu
Jue Xie
Chengping Wen
Liwei Lu
Liwei Lu
Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection
Frontiers in Immunology
COVID-19
SARS-CoV-2
Tfh cells
B cells
neutralizing antibody
author_facet Dawei Cui
Yuan Tang
Yuan Tang
Qi Jiang
Daixi Jiang
Yun Zhang
Yan Lv
Dandan Xu
Jian Wu
Jue Xie
Chengping Wen
Liwei Lu
Liwei Lu
author_sort Dawei Cui
title Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection
title_short Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection
title_full Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection
title_fullStr Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection
title_full_unstemmed Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection
title_sort follicular helper t cells in the immunopathogenesis of sars-cov-2 infection
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-09-01
description Coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a serious infectious disease that has led to a global pandemic with high morbidity and mortality. High-affinity neutralizing antibody is important for controlling infection, which is closely regulated by follicular helper T (Tfh) cells. Tfh cells play a central role in promoting germinal center reactions and driving cognate B cell differentiation for antibody secretion. Available studies indicate a close relationship between virus-specific Tfh cell-mediated immunity and SARS-CoV-2 infection progression. Although several lines of evidence have suggested that Tfh cells contribute to the control of SARS-CoV-2 infection by eliciting neutralizing antibody productions, further studies are needed to elucidate Tfh-mediated effector mechanisms in anti-SARS-CoV-2 immunity. Here, we summarize the functional features and roles of virus-specific Tfh cells in the immunopathogenesis of SARS-CoV-2 infection and in COVID-19 vaccines, and highlight the potential of targeting Tfh cells as therapeutic strategy against SARS-CoV-2 infection.
topic COVID-19
SARS-CoV-2
Tfh cells
B cells
neutralizing antibody
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.731100/full
work_keys_str_mv AT daweicui follicularhelpertcellsintheimmunopathogenesisofsarscov2infection
AT yuantang follicularhelpertcellsintheimmunopathogenesisofsarscov2infection
AT yuantang follicularhelpertcellsintheimmunopathogenesisofsarscov2infection
AT qijiang follicularhelpertcellsintheimmunopathogenesisofsarscov2infection
AT daixijiang follicularhelpertcellsintheimmunopathogenesisofsarscov2infection
AT yunzhang follicularhelpertcellsintheimmunopathogenesisofsarscov2infection
AT yanlv follicularhelpertcellsintheimmunopathogenesisofsarscov2infection
AT dandanxu follicularhelpertcellsintheimmunopathogenesisofsarscov2infection
AT jianwu follicularhelpertcellsintheimmunopathogenesisofsarscov2infection
AT juexie follicularhelpertcellsintheimmunopathogenesisofsarscov2infection
AT chengpingwen follicularhelpertcellsintheimmunopathogenesisofsarscov2infection
AT liweilu follicularhelpertcellsintheimmunopathogenesisofsarscov2infection
AT liweilu follicularhelpertcellsintheimmunopathogenesisofsarscov2infection
_version_ 1717378438092816384